JPS5692860A - 99chlorooprostaglandin derivative* its manufacture and prostaglandin derivative medicine - Google Patents

99chlorooprostaglandin derivative* its manufacture and prostaglandin derivative medicine

Info

Publication number
JPS5692860A
JPS5692860A JP17447980A JP17447980A JPS5692860A JP S5692860 A JPS5692860 A JP S5692860A JP 17447980 A JP17447980 A JP 17447980A JP 17447980 A JP17447980 A JP 17447980A JP S5692860 A JPS5692860 A JP S5692860A
Authority
JP
Japan
Prior art keywords
substituted
aryl
alpha
group
hydrocarbon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP17447980A
Other languages
English (en)
Other versions
JPS6224422B2 (ja
Inventor
Sukubara Buerunaa
Raadoyuhieru Berunto
Fuooaburiyutsugen Herumuuto
Erugaa Buarutaa
Rooge Oraafu
Shiringaa Etsukeharuto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of JPS5692860A publication Critical patent/JPS5692860A/ja
Publication of JPS6224422B2 publication Critical patent/JPS6224422B2/ja
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0041Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyrane Compounds (AREA)
JP17447980A 1979-12-10 1980-12-10 99chlorooprostaglandin derivative* its manufacture and prostaglandin derivative medicine Granted JPS5692860A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19792950027 DE2950027A1 (de) 1979-12-10 1979-12-10 9-chlor-prostaglandinderivate, verfahren zur herstellung und verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
JPS5692860A true JPS5692860A (en) 1981-07-27
JPS6224422B2 JPS6224422B2 (ja) 1987-05-28

Family

ID=6088285

Family Applications (1)

Application Number Title Priority Date Filing Date
JP17447980A Granted JPS5692860A (en) 1979-12-10 1980-12-10 99chlorooprostaglandin derivative* its manufacture and prostaglandin derivative medicine

Country Status (14)

Country Link
US (2) US4444788A (ja)
EP (1) EP0030377B1 (ja)
JP (1) JPS5692860A (ja)
AT (1) ATE6364T1 (ja)
AU (1) AU543797B2 (ja)
CA (1) CA1196327A (ja)
CS (1) CS226419B2 (ja)
DE (2) DE2950027A1 (ja)
DK (2) DK153944C (ja)
ES (1) ES497589A0 (ja)
HU (1) HU183263B (ja)
IE (1) IE51212B1 (ja)
IL (1) IL61669A (ja)
SU (1) SU1026652A3 (ja)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58121268A (ja) * 1981-12-04 1983-07-19 シエ−リング・アクチエンゲゼルシヤフト 9−ブロム−プロスタグランジン誘導体、その製法及び該誘導体を含有する医薬
JPS61501915A (ja) * 1984-04-13 1986-09-04 シエ−リング アクチエンゲゼルシヤフト 新規9−ハロゲン−プロスタグランジン
JPS62501561A (ja) * 1985-02-04 1987-06-25 シエ−リング アクチエンゲゼルシヤフト 9−ハロゲンプロスタグランジン−クラスレイト及びその医薬品としての使用
JPH0692362B2 (ja) * 1983-07-08 1994-11-16 シエ−リング アクチエンゲゼルシヤフト 11―ハロゲン―プロスタン誘導体及びその製法
JP2009516665A (ja) * 2005-11-21 2009-04-23 バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト 9−クロロ−15−デオキシプロスタグランジン誘導体類、それらの調製方法及び薬剤としてのそれらの使用

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2950027A1 (de) * 1979-12-10 1981-06-11 Schering Ag Berlin Und Bergkamen, 1000 Berlin 9-chlor-prostaglandinderivate, verfahren zur herstellung und verwendung als arzneimittel
US5204371A (en) * 1979-12-10 1993-04-20 Schering Aktiengesellschaft Pharmaceutically active 9-chloroprostaglandins
DE3126924A1 (de) * 1981-07-03 1983-01-20 Schering Ag, 1000 Berlin Und 4619 Bergkamen 9-fluor-prostaglandinderivate, verfahren zur herstellung und verwendung als arzneimittel
DE3337450A1 (de) * 1983-10-12 1985-04-25 Schering AG, 1000 Berlin und 4709 Bergkamen Prostaglandine und antigestagene fuer den schwangerschaftsabbruch
DE3347128A1 (de) * 1983-12-22 1985-07-11 Schering AG, 1000 Berlin und 4709 Bergkamen 9-halogen-(delta)(pfeil hoch)2(pfeil hoch)-prostaglandinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3510978A1 (de) * 1985-03-22 1986-09-25 Schering AG, Berlin und Bergkamen, 1000 Berlin Neue 9-halogenprostaglandine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3608088C2 (de) * 1986-03-07 1995-11-16 Schering Ag Pharmazeutische Präparate, enthaltend Cyclodextrinclathrate von Carbacyclinderivaten
DE3724190A1 (de) * 1987-07-17 1989-01-26 Schering Ag 9-halogen-3-oxa-(z)-(delta)(pfeil hoch)5(pfeil hoch)-prostaglandinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
AU624078B2 (en) * 1987-07-17 1992-06-04 Schering Aktiengesellschaft Berlin Und Bergkamen 9-halogen-(z)-prostaglandin derivatives, process for manufacturing them, and their use as drugs
IL87116A (en) 1987-07-17 1993-03-15 Schering Ag 9-halogen-(z)-prostaglandin derivatives and pharmaceutical compositions containing the same
US5891910A (en) * 1987-07-17 1999-04-06 Schering Aktiengesellschaft 9-halogen-(Z) prostaglandin derivatives, process for their production and their use as pharmaceutical agents
DE3724189A1 (de) * 1987-07-17 1989-01-26 Schering Ag 9-halogen-(z)-(delta)(pfeil hoch)4(pfeil hoch)-prostaglandinderivate, verfahren zu ihrer herstellung und ihrer verwendung als arzneimittel
DE4036140A1 (de) * 1990-11-09 1992-05-14 Schering Ag 9-halogen-11ss-hydroxy-prostaglandinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
EP0652211A1 (en) * 1992-07-24 1995-05-10 Taisho Pharmaceutical Co. Ltd Prostaglandin derivative
DE4229048A1 (de) * 1992-08-31 1994-03-03 Schering Ag Ester von 9-Chlor-Prostaglandinen, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
DE4229050A1 (de) * 1992-08-31 1994-03-03 Schering Ag Neue 9-Chlor-Prostaglandin-Ester und -amide
ATE166642T1 (de) * 1992-08-31 1998-06-15 Schering Ag 9-chlor-prostaglandin-ester und -amide und ihre verwendung für die herstellung von arzneimitteln
US5972991A (en) * 1992-09-21 1999-10-26 Allergan Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
IT1257479B (it) * 1992-12-01 1996-01-25 Derivati prostaglandinici aventi effetti radioprotettivi
DE4330177A1 (de) * 1993-08-31 1995-03-02 Schering Ag Neue 9-Chlor-prostaglandin-derivate
US5721273A (en) * 1993-12-15 1998-02-24 Alcon Laboratories, Inc. Use of certain 9-halo-13,14-dihydroprostaglandins to treat glaucoma and ocular hypertension
US5807892A (en) * 1994-09-30 1998-09-15 Alcon Laboratories, Inc. Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension
US6235780B1 (en) 1998-07-21 2001-05-22 Ono Pharmaceutical Co., Ltd. ω-cycloalkyl-prostaglandin E1 derivatives
US7563924B2 (en) * 2005-11-21 2009-07-21 Schering Aktiengesellschaft 9-chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2517773A1 (de) * 1975-04-18 1976-10-28 Schering Ag Neue 11-oxo-prostaglandin-derivate und verfahren zu ihrer herstellung
US4163016A (en) * 1977-07-05 1979-07-31 Hoffmann-La Roche Inc. 16-Substituted prostaglandins
US4192799A (en) * 1977-09-21 1980-03-11 The Upjohn Company Conjugates formed by reacting a prostaglandin mimic compound with a carrier molecule
DE2950027A1 (de) * 1979-12-10 1981-06-11 Schering Ag Berlin Und Bergkamen, 1000 Berlin 9-chlor-prostaglandinderivate, verfahren zur herstellung und verwendung als arzneimittel

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58121268A (ja) * 1981-12-04 1983-07-19 シエ−リング・アクチエンゲゼルシヤフト 9−ブロム−プロスタグランジン誘導体、その製法及び該誘導体を含有する医薬
JPH0692362B2 (ja) * 1983-07-08 1994-11-16 シエ−リング アクチエンゲゼルシヤフト 11―ハロゲン―プロスタン誘導体及びその製法
JPS61501915A (ja) * 1984-04-13 1986-09-04 シエ−リング アクチエンゲゼルシヤフト 新規9−ハロゲン−プロスタグランジン
JPS62501561A (ja) * 1985-02-04 1987-06-25 シエ−リング アクチエンゲゼルシヤフト 9−ハロゲンプロスタグランジン−クラスレイト及びその医薬品としての使用
JP2009516665A (ja) * 2005-11-21 2009-04-23 バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト 9−クロロ−15−デオキシプロスタグランジン誘導体類、それらの調製方法及び薬剤としてのそれらの使用

Also Published As

Publication number Publication date
IE51212B1 (en) 1986-11-12
EP0030377A1 (de) 1981-06-17
AU6519080A (en) 1981-06-18
CA1196327A (en) 1985-11-05
DE2950027A1 (de) 1981-06-11
IE802572L (en) 1981-06-10
HU183263B (en) 1984-04-28
DK526080A (da) 1981-06-11
ES8200336A1 (es) 1981-11-16
US4444788A (en) 1984-04-24
ES497589A0 (es) 1981-11-16
EP0030377B1 (de) 1984-02-22
DK153944C (da) 1989-02-20
US5079259A (en) 1992-01-07
IL61669A0 (en) 1981-01-30
IL61669A (en) 1986-08-31
ATE6364T1 (de) 1984-03-15
DK153944B (da) 1988-09-26
AU543797B2 (en) 1985-05-02
SU1026652A3 (ru) 1983-06-30
DK573687A (da) 1987-11-02
DE3066726D1 (en) 1984-03-29
DK573687D0 (da) 1987-11-02
CS226419B2 (en) 1984-03-19
JPS6224422B2 (ja) 1987-05-28

Similar Documents

Publication Publication Date Title
JPS5692860A (en) 99chlorooprostaglandin derivative* its manufacture and prostaglandin derivative medicine
US4111995A (en) 2-Decarboxy-2-hydroxymethyl-ω-phenoxy-PGD analogs
ATE12094T1 (de) Neue carbacycline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
AU559449B2 (en) 9-fluoroprostaglandin analogs
NO154921C (no) Fremgangsmaate ved fremstilling av en kationbyttermembran.
IE46036L (en) Prostacyclin and derivatives thereof
MX9203752A (es) Novedosos derivados de acido p-oxibenzoico y procedimiento para la preparacion de los mismos y su uso como medicamentos.
ES8105270A1 (es) Un procedimiento para preparar un antibiotico de tipo a-30912h
ES536649A0 (es) Procedimiento para la preparacion de derivados de estrano y androstano
SE7706245L (sv) Forfarande for framstellning av prostacyklinderivat
IE43461L (en) Cyclopropane derivatives.
CH609682A5 (en) Process for the preparation of compounds analogous to prostaglandins
GB1473670A (en) Process for the manufacture of prostaglandin-f2a and analogues thereof
ES395036A2 (es) Procedimiento para producir un compuesto opticamente acti- vo.
JPS52131557A (en) Synthesis of epoxycyclo pentanone derivatives
ATE8259T1 (de) Neue prostacyclinderivate und ihre herstellung.
GB1484986A (en) Salts of the dimethylaminoethyl ester of p-chloro-phenoxy acetic acid
GB1537199A (en) Intermediates in the preparation of sterols
GB991475A (en) Novel steroid compounds and processes for their production
ES445304A1 (es) Un procedimiento para la produccion de nuevos compuestos de 6, 11-dihidrodibenzo (b, e,) tiepin-11-ona.